Coverage
-
March 28, 2017
Swiss pharmaceutical giant Novartis scored a partial victory Tuesday when a Delaware federal judge said three drugmakers induced infringement of its patents when they filed abbreviated new drug applications for a generic version of Zortress, a medication used to treat organ transplant recipients.
1 other articles on this case.
View all »